Circulating oxidized low-density lipoprotein and common carotid artery intima-media thickness in a random sample of middle-aged men

Journal of Biomedical Science

Volumn 11, Issue 3, 2004, Pages 356-361

  Metso, S ^a   Loimaala, A ^b   Mercuri, M F ^c   Nenonen, A ^a,b   Vuori, I ^b   Oja, P ^b   Bond, M G ^c   Laine, S ^a   Rontu, R ^a   Lehtimäki, Terho ^a,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Atherosclerosis; Carotid artery; Intima media thickness; Low density lipoprotein; Oxidized

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD SAMPLING; CAROTID ARTERY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FINLAND; HUMAN; INTERNAL CAROTID ARTERY; INTIMA; LIPOPROTEIN BLOOD LEVEL; MALE; POPULATION RESEARCH; PRESSURE; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TUNICA MEDIA;

CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TUNICA INTIMA;

EID: 11144358281     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000077104     Document Type: Article

References (15)

1. Fukumoto M, Shoji T, Emoto M, Kawagishi T, Okuno Y, Nishizawa Y. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 20:703-707;2000.
2. Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, Liu CH, Hwang J, Selzer RH, Azen SP; VEAPS Research Group. Alphatocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106:1453-1459;2002.
3. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de Verf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21:844-848;2001.
4. Huang XH, Loimaala A, Nenonen A, Mercuri M, Vuori I, Pasanen M, Oja P, Bond G, Koivula T, Hiltunen TP, Nikkari T, Lehtimäki T. Relationship of angiotensin-converting enzyme gene polymorphism to carotid wall thickness in middle-aged men. J Mol Med 77:853-858;1999.
5. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 22:1162-1167;2002.
6. Joensuu T, Salonen R, Winblad I, Korpela H, Salonen JT. Determinants of femoral and carotid artery atherosclerosis. J Intern Med 236:79-84;1994.
7. Mercuri M. Noninvasive imaging protocols to detect and monitor carotid atherosclerosis progression. Am J Hypertens 7(7 pt 2):23S-29S; 1994.
8. Metso S, Nikkila M, Laippala P, Jaakkola O, Solakivi T, Lehtimaki T. Oxidized LDL autoantibodies are related to apolipoprotein E phenotype, independently of postprandial change in plasma triglycerides and LDL size, among patients with angiographically verified coronary artery disease and healthy controls. J Biomed Sci 10:345-351;2003.
9. Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, Nagahiro S. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol 22:1649-1654;2002.
10. Riley WA, Barnes RW, Applegate WB, Dempsey R, Hartwell T, Davis VG, Bond MG, Furberg CD. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke 23:1062-1068;1992.
11. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887;1992.
12. Tell GS, Howard G, McKinney WM. Risk factors for site-specific extracranial carotid artery plaque distribution as measured by B-mode ultrasound. J Clin Epidemiol 42:551-559;1989.
13. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, Nagai R. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20:2243-2247;2000.
14. Vasankari T, Ahotupa M, Toikka J, Mikkola J, Irjala K, Pasanen P, Neuvonen K, Raitakari K, Viikari J. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: Lower levels of oxidized LDL with statin therapy. Atherosclerosis 155:403-412;2001.
15. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792;1991.